FIELD: organic chemistry, medicine, molecular pathology. SUBSTANCE: invention proposes the application of one or some compounds among the group consisting of fumaric acid dialkyl esters and monoalkyl esters as free acid or its salts as an agent for treatment of disease caused by damage of oxidative phosphorylation and taken among the group including Parkinson's disease, Alzheimers's disease, Huntington's chorea, pigmentary retinopathy and mitochondrial encephalomyopathy. EFFECT: valuable medicinal properties of compounds, expanded assortment of agents of indicated designation. 10 cl, 1 tbl, 4 ex
| Title | Year | Author | Number |
|---|---|---|---|
| DERIVATIVES OF FUMARIC ACID AS NF-kappaB INHIBITOR | 2002 |
|
RU2282440C2 |
| USING DERIVATIVES OF FUMARIC ACID IN TREATMENT OF CARDIAC INSUFFICIENCY AND ASTHMA | 2004 |
|
RU2313339C2 |
| USING FUMARIC ACID DERIVATIVES FOR TREATING CARDIAC FAILURE, MYOCARDIAL INFARCTION AND ANGINA | 2007 |
|
RU2459621C2 |
| APPLICATION OF ACID ALKYLFUMARATES FOR TREATMENT OF PSORIASIS, PSORIATIC ARTHRITIS, NEURODERMITIS AND CHRONIC CICATRIZING ENTERITIS (CROHN'S DISEASE) | 1998 |
|
RU2197233C2 |
| APPLICATION OF DERIVATIVES OF FUMARIC ACID IN TRANSPLANTATION MEDICINE | 1999 |
|
RU2210364C2 |
| FUMARIC ACID-BASE MICROTABLETS | 1999 |
|
RU2210366C2 |
| APPLICATION OF FUMARIC ACID DERIVATIVES | 1998 |
|
RU2197963C2 |
| AGENT FOR TREATMENT OF DISEASE CAUSED BY OXIDATIVE STRESS | 2018 |
|
RU2674286C1 |
| FUMARIC ACID AMIDES | 2002 |
|
RU2290946C2 |
| PHARMACEUTICAL COMPOSITIONS COMPRISING DERIVATIVES OF HYDROXAMIC ACID | 1996 |
|
RU2191005C2 |
